Please join COMPASS Pathways for a virtual key opinion leader (KOL) event featuring Gary W Small, MD (Hackensack University Medical Center), who will join company management and three of COMPASS Pathway’s collaboration partners, Geoff Grammer, MD, CMO (Greenbrook Mental Wellness Centers), Myriam Barthes (co-founder & CEO, Journey Clinical), and Dimitri Cavathas (CEO, HealthPort).

Dr. Small will highlight the current landscape and unmet need in treatment-resistant depression (TRD), and the company’s collaboration partners will discuss patient care pathways, provider economics for multi-hour treatments, and the development of treatment models in TRD. COMPASS Pathways’ management team will review commercial readiness activities and the emerging profile of COMP360 in TRD, as well as highlight the unmet need in post-traumatic stress disorder (PTSD) and provide details of the planned late-stage program for COMP360 in this indication.

A live question and answer session will follow the formal presentations.